site background
Skip to content
Ivy Brain Tumor Center
Main Menu
  • ESPAÑOL
  • Donate
  • Blog
  • TRIAL ELIGIBILITY
Talk to an Ivy Navigator
  • Brain Tumor Care
    • Tumor Types
      • Glioblastoma
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Other Tumors
    • Brain Tumor Treatment
      • Neurosurgery
      • Neuro-Oncology
      • Radiation Oncology
      • Neuroimaging
    • Supportive Care
      • Neuro-Rehabilitation
      • Neuropsychology
      • Palliative Care
      • Support Groups
      • Social Work Services
  • Clinical Trials
    • Current Trials
    • Phase 0 Clinical Trials
    • Trial Screening
  • Our Specialists
  • Patient & Caregiver Resources
    • Advocacy & Support Groups
    • Patient & Visitor Information
      • Lodging
      • Transportation
    • Patient Stories
    • Blog
  • Research
    • Scientific Cores
    • Labs
    • Certifications
    • Preclinical Research
    • Industry Partnerships
    • Published Research
  • About
    • Newsroom
    • Careers
    • How You Can Help
    • Events
    • Contact Us

Talk to an Ivy Navigator

602-406-8605
About Team Nader Sanai, MD
Sanai New Headshot
  • phone:(602) 406-3135
  • View Doctor Profile

Nader Sanai, MD

Director, Ivy Brain Tumor Center and Chief of Neurosurgical Oncology, Barrow Neurological Institute

Nader Sanai, MD, is the Francis & Dionne Najafi Chair in Neurosurgical Oncology at the Barrow Neurological Institute.  An internationally acclaimed neurosurgeon and one of the nation’s highest-volume brain tumor surgeons, Dr. Sanai has built a specialty clinical practice devoted to patients with benign and malignant brain tumors, particularly those in high-risk areas. He is an expert in intraoperative brain mapping techniques, which identify and preserve areas of motor, sensory, and language function during brain surgery.  In 2016, Dr. Sanai was elected to the American Academy of Neurological Surgeons, the most respected academic organization in neurosurgery.

Dr. Sanai’s brain tumor research efforts are funded by over a dozen external granting agencies, including the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Dr. Sanai is one of only a handful of neurosurgeons in the United States serving as the principal investigator for multiple NIH and NCI R01 grants and the only neurosurgeon to have led multiple research studies reported in the journals Nature and The New England Journal of Medicine.  Dr. Sanai has authored more than 300 peer-reviewed publications and delivered over 200 national and international lectures in neuro-oncology.  Collectively, Dr. Sanai’s published research has led to over 30,000 total citations in academic literature.

Dr. Sanai oversees all brain tumor research at the Barrow Neurological Institute.  In 2018, he founded and now directs the Ivy Brain Tumor Center, a not-for-profit drug development program for brain tumor patients.  The Ivy Center is supported by the Ben & Catherine Ivy Foundation, the Barrow Neurological Foundation, and the Barrow Neurological Institute.  Its precision medicine program is the first of its kind worldwide and it specializes in clinical trials designed to accelerate drug development.  In 2023, the Ivy Center and the biopharmaceutical company, GSK, reported promising results from a Phase 0 trial in newly diagnosed glioblastoma patients.  To translate these findings into the first life-prolonging glioblastoma drug approval in decades, the Ivy Brain Tumor Center announced the initiation of a global Phase 3 clinical trial across 11 countries. 

Click here to learn more about Dr. Sanai and why the fight against brain cancer is personal to him.

Back to Top
St Joesph Hospital

Stay Informed

Stay up to date on the latest in brain tumor research, treatment and community events.

Ivy Brain Tumor Center

About Ivy Brain Tumor Center

The Ivy Brain Tumor Center at Barrow Neurological Institute in Phoenix, AZ, is a tertiary care and nonprofit translational research program that employs bold, early-phase clinical trial strategies to identify new treatments for aggressive brain tumors, including glioblastoma. Our leading experts in neurosurgical oncology, neuro-oncology, radiation oncology, neuroradiology, neuropathology and neuroscience nursing treat more patients annually than any other brain tumor center in the United States. The Ivy Center’s Phase 0 clinical trials program is the largest in the world and enables personalized care in a fraction of the time and cost associated with traditional drug development. In addition, unlike conventional clinical trials focusing on single drugs, the Ivy Center’s accelerated program tests therapeutic combinations matched to individual patients. We leave no stone unturned in the pursuit of hope and healing.

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

Barrow Neurological Institute

HIPAA Notice of Privacy Practices  |  Legal Notices  | Internet Privacy Notice  |  Online Accessibility Notice  |  Organized Health Care Arrangement (OHCA)

Patient Rights and Responsibilities  |  Site Map

© 2024 Ivy Brain Tumor Center

Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.